Automobile Driving Clinical Trial
— VALIDADOfficial title:
Development of a Valid Test Battery for Assessing Driving Ability When Influenced by Drugs.
Verified date | September 2017 |
Source | St. Olavs Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the validation study is to develop a valid test battery for assessing driving ability in a driving simulator when influenced by drugs. Ethanol has known, well-documented and well-characterized effects on driving behaviour and accident risk, and will be used to assess the simulator test scenarios' sensitivity to drug effects. Once the test scenarios have been refined and their ability to predict driving accident risk have been validated, we plan to use the simulator to assess driving ability under the influence of different drugs suspected to produce driving impairment.
Status | Completed |
Enrollment | 20 |
Est. completion date | November 2010 |
Est. primary completion date | November 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 25 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Healthy, caucasian males aged 25-50 years in possession of a valid driver's license for the last 5 years. - Recreational alcohol drinkers without alcohol dependence or abuse, no traffic-related convictions or alcohol-influenced behavioural disturbances. - 1 or 0 points on the modified Apfel scale for predicting post-operative nausea/vomiting (non-smoker, previously experienced nausea/vomiting post-operatively, previously experienced motion sickness) Exclusion Criteria: - Females (risk of teratogenicity) - Non-caucasian ethnicity (possibility of deviant ethanol metabolism) - Previous strong reactions such as nausea, fainting etc. during blood sampling - Previous abnormal reactions to ethanol - Previous convictions related to drug intoxication - Previous excessive drug use - Regular use of prescription drugs - Two points or more according to the modified Apfel criteria |
Country | Name | City | State |
---|---|---|---|
Norway | SINTEF Health and Research | Trondheim |
Lead Sponsor | Collaborator |
---|---|
St. Olavs Hospital | Norwegian Institute of Public Health, Norwegian University of Science and Technology, SINTEF Health Research |
Norway,
Helland A, Jenssen GD, Lervåg LE, Moen T, Engen T, Lydersen S, Mørland J, Slørdal L. Evaluation of measures of impairment in real and simulated driving: Results from a randomized, placebo-controlled study. Traffic Inj Prev. 2016;17(3):245-50. doi: 10.1080 — View Citation
Helland A, Jenssen GD, Lervåg LE, Westin AA, Moen T, Sakshaug K, Lydersen S, Mørland J, Slørdal L. Comparison of driving simulator performance with real driving after alcohol intake: a randomised, single blind, placebo-controlled, cross-over trial. Accid — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Standard deviation of lateral position on road (SDLP) | Instantly (while the subject is inebriated) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05096000 -
InterMob: a Randomized Controlled Trial Aimed at Reducing Car Use in Regular Car Users
|
N/A | |
Recruiting |
NCT05163119 -
Randomized Trial on Mobile Technology and Young Drivers' Cellphone Use
|
N/A | |
Recruiting |
NCT06290037 -
Driving Ability Evaluation System to Improve the Conditional Driving License System: Feasibility Study of High-risk Drivers.
|
N/A | |
Recruiting |
NCT06279520 -
Driving Ability Evaluation System to Improve the Conditional Driving License System: Safety and Feasibility Study.
|
N/A | |
Withdrawn |
NCT01257165 -
Driving Simulator Performance After Intake of Zopiclone Sleeping Pills
|
N/A |